Lu Yu
5 Papers
Lu Yu is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 5 publications.
Chat about Author
Papers
The “m6A writer” METTL3 and the “m6A reader” IGF2BP2 regulate cutaneous T‐cell lymphomas progression via CDKN2A
TL;DR: This is the first study to depict the role of m6A in CTCL development and provide potential bio‐targets for therapy and show that the decline in METTL3 levels was responsible for C TCL cell proliferation and migration.
9
Impact of Radiation Dose to the Immune System on Disease Progression and Survival for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
Xiaofeng Wang,Hui Bai,Miao Gao,Yong Guan,Lu Yu,Yang Dong,Yongchun Song,Zhen Tao,Mao-Bin Meng,Zhiqiang Wu,Lu Jun Zhao,Zhiyong Yuan +11 more
TL;DR: EDRIC was an independent predictor of CSS and DMFS in ES-NSCLC, and it was affected by GTV and tumor location, and the feasibility of achieving lower EDRIC while maintaining adequate tumor coverage during radiotherapy are warranted.
7
Real‐world data for lenalidomide maintenance in responding patients of diffuse large B‐cell lymphoma
TL;DR: In this paper , the clinical effect of lenalidomide maintenance therapy in responding DLBCL patients with R•CHOP treatment was evaluated. And the results showed that the maintenance therapy was promising in long-term maintenance therapy.
3
Stereotactic body radiotherapy compared with video‐assisted thoracic surgery after propensity‐score matching in elderly patients with pathologically‐proven early‐stage non‐small cell lung cancer
Xiao‐ye Liu,Miao Gao,Ze‐yuan Cheng,Zheng‐Kun Cai,Lu Yu,Geng‐Min Niu,Jun-yi Li,Yu-Lin Bai,Shu‐Zhou Zhao,Yongchun Song,Xiaoguang Wang,Yang Dong,Xuyao Yu,Zhen Tao,Zhiyong Yuan +14 more
TL;DR: In this paper, the stereotactic body radiotherapy (SBRT) can be a viable substitute for elderly patients who can no longer tolerate or refuse surgery for early non-small cell lung cancer.
2
[Prognosis Analysis of Early-stage Non-small Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy].
Lu Yu,Miao Gao,Xiaofeng Wang,Huihui Bai,Yong Guan,Zhiyong Yuan +5 more
- 20 Apr 2023
TL;DR: In this paper , the authors investigated the prognosis of early-stage lung cancer patients treated with Stereotactic Body Radiation Therapy (SBRT) and its influencing factors in order to reduce the side effects of radiotherapy and improve the survival and quality of life.
1